Serum aryl hydrocarbon receptor ligand activity is associated with insulin resistance and resulting type 2 diabetes

Acta Diabetologica

Volumn 52, Issue 3, 2015, Pages 489-495

  Roh, Eun ^a,b,e   Kwak, Soo Heon ^a   Jung, Hye Seung ^a   Cho, Young Min ^a,b   Pak, Youngmi Kim ^c   Park, Kyong Soo ^a,b,e   Kim, Seong Yeon ^a,b   Lee, Hong Kyu ^d  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

^d Eulji University   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Aryl hydrocarbon receptor; Dioxins; Insulin resistance; Persistent organic pollutants; Type 2 diabetes

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; DIOXIN; GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL; LIGAND;

ADULT; ARTICLE; BLOOD LEVEL; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; DIOXIN BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KOREAN (PEOPLE); MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; AGED; BLOOD; CHEMISTRY; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; METABOLISM; MIDDLE AGED;

AGED; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIOXINS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; LIGANDS; MALE; MIDDLE AGED; RECEPTORS, ARYL HYDROCARBON;

EID: 84930085032     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-014-0674-z     Document Type: Article

References (34)

1. Schecter A, Birnbaum L, Ryan JJ, Constable JD (2006) Dioxins: an overview. Environ Res 101(3):419–428
2. Qing Li Q, Loganath A, Seng Chong Y, Tan J, Philip Obbard J (2006) Persistent organic pollutants and adverse health effects in humans. J Toxicol Environ Health A 69(21):1987–2005
3. Vasseur P, Cossu-Leguille C (2006) Linking molecular interactions to consequent effects of persistent organic pollutants (POPs) upon populations. Chemosphere 62(7):1033–1042
4. Gilpin RK, Wagel DJ, Solch JG (2003) Production, Distribution, and Fate of Polychlorinated Dibenzo-p-Dioxins, Dibenzofurans, and Related Organohalogens in the Environment. In: Schecter A, Gasiewicz TA (eds) Dioxins and health, 2nd edn. Wiley, Hoboken, pp 89–136
5. Mandal PK (2005) Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. J Comp Physiol B 175(4):221–230
6. Poland A, Knutson JC (1982) 2,3,7,8-tetrachlorodibenzo-thorn-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 22(1):517–554
7. Fernandez-Salguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ (1996) Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol Appl Pharmacol 140(1):173–179
8. Van den Berg M, Birnbaum L, Bosveld ATC, Brunström B, Cook P, Feeley M, Giesy JP, Hanberg A, Hasegawa R, Kennedy SW, Kubiak T, Larsen JC, Van Leeuwen FX, Liem AK, Nolt C, Peterson RE, Poellinger L, Safe S, Schrenk D, Tillitt D, Tysklind M, Younes M, Warn F, Zacharewski T (1998) Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 106(12):775–792
9. Longnecker MP, Michalek JE (2000) Serum dioxin level in relation to diabetes mellitus among air force veterans with background levels of exposure. Epidemiology 11(1):44–48
10. Fierens S, Mairesse H, J-f Heilier, De Burbure C, J-f Focant, Eppe G, De Pauw E, Bernard A (2003) Dioxin/polychlorinated biphenyl body burden, diabetes and endometriosis: findings in a population-based study in Belgium. Biomarkers 8(6):529–534
11. Lee DH, Lee IK, Song K, Steffes M, Toscano W, Baker BA, Jacobs DR Jr (2006) A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes results from the National Health and Examination Survey 1999–2002. Diabetes Care 29(7):1638–1644
12. Cox S, Niskar AS, Narayan KV, Marcus M (2007) Prevalence of self-reported diabetes and exposure to organochlorine pesticides among Mexican Americans: hispanic health and nutrition examination survey, 1982–1984. Environ Health Perspect 115:1747–1752
13. Wang SL, Tsai PC, Yang CY, Guo YL (2008) Increased risk of diabetes and polychlorinated biphenyls and dioxins: a 24-year follow-up study of the Yucheng cohort. Diabetes Care 31(8):1574–1579
14. Ukropec J, Radikova Z, Huckova M, Koska J, Kocan A, Sebokova E, Drobná B, Trnovec T, Susienkova K, Labudova V, Gasperíková D, Langer P, Klimes I (2010) High prevalence of prediabetes and diabetes in a population exposed to high levels of an organochlorine cocktail. Diabetologia 53(5):899–906
15. Airaksinen R, Rantakokko P, Eriksson JG, Blomstedt P, Kajantie E, Kiviranta H (2011) Association between type 2 diabetes and exposure to persistent organic pollutants. Diabetes Care 34(9):1972–1979
16. Taylor KW, Novak RF, Anderson HA, Birnbaum LS, Blystone C, DeVito M, Jacobs D, Köhrle J, Lee D-H, Rylander L, Rignell-Hydbom A, Tornero-Velez R, Turyk ME, Boyles AL, Thayer KA, Lind L (2013) Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review. Environ Health Perspect 121(7):774–783
17. Lee DH, Steffes MW, Sjödin A, Jones RS, Needham LL, Jacobs DR Jr (2010) Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case–control study. Environ Health Perspect 118(9):1235–1242
18. Lee HK (2011) Mitochondrial dysfunction and insulin resistance: the contribution of dioxin-like substances. Diabetes Metab J 35(3):207–215
19. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, Shioda T, Soto AM, vom Saal FS, Welshons WV, Zoeller RT, Myers JP (2012) Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 33(3):378–455
20. Barouki R, Coumoul X, Fernandez-Salguero PM (2007) The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein. FEBS Lett 581(19):3608–3615
21. Park WH, Jun DW, Kim JT, Jeong JH, Park H, Chang YS, Park KS, Lee HK, Pak YK (2013) Novel cell-based assay reveals associations of circulating serum AhR-ligands with metabolic syndrome and mitochondrial dysfunction. Biofactors 39(4):494–504
22. American Diabetes Association (2013) Standards of medical care in diabetes, 2013. Diabetes Care 36:S11–S66
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419
24. Lim J-e, Jee SH (2014) Association between serum levels of adiponectin and polychlorinated biphenyls in Korean men and women. Endocrine. doi:10.1007/s12020-014-0231-0 [Epub ahead of print]
25. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86(5):1930–1935
26. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8(11):1288–1295
27. Porta M (2006) Persistent organic pollutants and the burden of diabetes. The Lancet 368(9535):558–559
28. Enan E, Matsumura F (1994) 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced changes in glucose transporting activity in guinea pigs, mice, and rats in vivo and in vitro. J Biochem Toxicol 9(2):97–106
29. Kurita H, Yoshioka W, Nishimura N, Kubota N, Kadowaki T, Tohyama C (2009) Aryl hydrocarbon receptor-mediated effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on glucose-stimulated insulin secretion in mice. J Appl Toxicol 29(8):689–694
30. Sato S, Shirakawa H, Tomita S, Ohsaki Y, Haketa K, Tooi O, Santo N, Tohkin M, Furukawa Y, Gonzalez FJ, Komai M (2008) Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver. Toxicol Appl Pharmacol 229(1):10–19
31. Wang C, Xu C-X, Krager SL, Bottum KM, Liao D-F, Tischkau SA (2011) Aryl hydrocarbon receptor deficiency enhances insulin sensitivity and reduces PPAR-α pathway activity in mice. Environ Health Perspect 119(12):1739–1744
32. Patterson DG Jr, Hampton L, Lapeza CR Jr, Belser WT, Green V, Alexander L, Needham LL (1987) High-resolution gas chromatographic/high-resolution mass spectrometric analysis of human serum on a whole-weight and lipid basis for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Anal Chem 59(15):2000–2005
33. Ziccardi MH, Gardner IA, Denison MS (2000) Development and modification of a recombinant cell bioassay to directly detect halogenated and polycyclic aromatic hydrocarbons in serum. Toxicol Sci 54(1):183–193
34. Kim JT, Kim SS, Jun DW, Hwang YH, Park WH, Pak YK, Lee HK (2013) Serum arylhydrocarbon receptor transactivating activity is elevated in type 2 diabetic patients with diabetic nephropathy. J Diabetes Investig 4(5):483–491